跳至主要内容
临床试验/NCT03512574
NCT03512574已完成4 期

The Effect of the Combination of Pregabalin and Dexmedetomidine on the Management of Postoperative Pain in Patients Undergoing Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA) Under Spinal Anesthesia

Wonkwang University Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2018年1月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
150
试验地点
1
主要终点
Patient controlled analgesics (PCA) volume

研究概览

简要总结

Pregabalin and dexmedetomidine have been introduced to manage postoperative pain. The present study aimed to evaluate the effect of the combination of two drugs on pain relief in patients undergoing total knee or hip arthroplasty under spinal anesthesia

详细描述

One hundred and twenty-four patients undergoing total knee or hip arthroplasty under spinal anesthesia were randomly assigned to either group C (n = 31, placebo), group P (n = 33, pregabalin), group PD (n = 29, pregabalin and dexmedetomidine) or group D (n = 31, dexmedetomidine). One hour before spinal anesthesia, patients received pregabalin 150 mg or placebo orally and a bolus dose of 0.5 μg /kg IV dexmedetomidine was given over 10 min before induction of spinal anesthesia, followed by a continuous infusion of 0.5 μg/kg/hr or the same calculated volume of normal saline till completion of the surgery. Clinically relevant pain for 24 h after surgery including time to first analgesic request visual analog scale (VAS), ketorolac dose, and patient controlled analgesics (PCA) volume consumed were recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-75 years
  • One hundred and twenty-four patients with intact cognitive function to understand this study undergoing elective total knee or hip arthroplasty under spinal anesthesia

排除标准

  • Allergic and/or contraindicated to the study drugs
  • American Society of Anesthesiologists (ASA) score III and above
  • Having drug
  • Alcohol addiction
  • Renal failure
  • Diabetes mellitus
  • currently using opioids for chronic pain and/or any of the drugs studied.

研究组 & 干预措施

Group PD

Experimental

combination of pregabalin and dexmedetomidine

干预措施: Pregabalin and dexmedetomidine (Drug)

Group P

Active Comparator

pregabalin +placebo

干预措施: Pregabalin (Drug)

Group D

Active Comparator

placebo + dexmedetomidine

干预措施: Dexmedetomidine (Drug)

Group C

Placebo Comparator

placebo + placebo

干预措施: Placebo (Other)

结局指标

主要结局

Patient controlled analgesics (PCA) volume

时间窗: For 24 hours

Patient controlled analgesics (PCA) volume consumed for 24 hours after surgery

次要结局

  • time to first analgesic request(for 24 hours)
  • visual analog scale (VAS)(for 24 hours)
  • ketorolac dose(for 24 hours)
  • adverse effects(within the first 24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cheol Lee

Professor,M.D.,Ph.D

Wonkwang University Hospital

研究点 (1)

Loading locations...

相似试验